[
    [
        {
            "time": "",
            "original_text": "瑞科生物冲刺港交所：单季亏损2.5亿 君联与红杉是股东 亏损",
            "features": {
                "keywords": [
                    "瑞科生物",
                    "港交所",
                    "单季亏损",
                    "君联",
                    "红杉",
                    "股东"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "瑞科生物冲刺港交所：单季亏损2.5亿 君联与红杉是股东 亏损",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "瑞科生物拟在港上市：斥巨资购买新冠疫苗专利，亏损规模持续扩大 亏损",
            "features": {
                "keywords": [
                    "瑞科生物",
                    "港上市",
                    "新冠疫苗",
                    "专利",
                    "亏损规模",
                    "持续扩大"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "瑞科生物拟在港上市：斥巨资购买新冠疫苗专利，亏损规模持续扩大 亏损",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药行业周报：中报预告落地 个股表现持续分化",
            "features": {
                "keywords": [
                    "医药行业",
                    "周报",
                    "中报预告",
                    "个股表现",
                    "持续分化"
                ],
                "sentiment_score": -0.3,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业周报：中报预告落地 个股表现持续分化",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        }
    ]
]